WHITNEY REIMER: Open Payments
NPI 1639841620 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$932 in 23 payments from 11 companies in 2025. Trend: 2023 $205 · 2024 $547 · 2025 $932
Food & beverage: $932
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 3 | $298 |
| Novartis Pharmaceuticals Corporation | 5 | $161 |
| Edwards Lifesciences Corporation | 1 | $115 |
| Cardiac Dimensions, Inc. | 3 | $68 |
| Baxter Healthcare | 3 | $66 |
| Actelion Pharmaceuticals US, Inc. | 2 | $65 |
| BridgeBio Pharma, Inc. | 2 | $60 |
| Ethicon US, LLC | 1 | $39 |
| Kestra Medical Technology Services, Inc. | 1 | $29 |
| Octapharma USA, Inc. | 1 | $17 |
Products named: LEQVIO, MITRIS RESILIA Mitral Valve, Hillrom - Carnation Ambulatory Monitor, OPSUMIT, Attruby, PROLENE, Assure WCD, FIBRYGA.
Industry payments across TX — which companies pay providers there.
